VRDN
Viridian Therapeutics Inc
NASDAQ: VRDN · HEALTHCARE · BIOTECHNOLOGY
$13.30
-2.28% today
Updated 2026-04-29
Market cap
$1.37B
P/E ratio
—
P/S ratio
19.35x
EPS (TTM)
$-3.32
Dividend yield
—
52W range
$12 – $34
Volume
2.3M
WallStSmart proprietary scores
35
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A7.3
Quality
B+2.5
Profitability
F5.0
Valuation
C+3/9
Piotroski F-Score
Weak
3.5
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$33.56
+152.33%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
3 Strong Buy14 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 3.53 — safe zone
+ Revenue growth 83.30% QoQ
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-23.99M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.77M | $314000.00 | $302000.00 | $70.85M | $70.85M |
| Net income | $-129.87M | $-237.73M | $-269.95M | $-342.60M | $-120.36M |
| EPS | — | — | — | — | $-3.32 |
| Free cash flow | $-94.64M | $-185.07M | $-232.83M | $-276.89M | $-23.99M |
| Profit margin | -7,329.23% | -75,711.46% | -89,387.09% | -483.57% | — |
Peer comparison
Smart narrative
Viridian Therapeutics Inc trades at $13.30. Our Smart Value Score of 35/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 3.53, it sits in the safe zone. TTM revenue stands at $70.85M.
Frequently asked questions
What is Viridian Therapeutics Inc's stock price?
Viridian Therapeutics Inc (VRDN) trades at $13.30.
Is Viridian Therapeutics Inc overvalued?
Smart Value Score 35/100 (Grade D, Sell).
What is the price target of Viridian Therapeutics Inc (VRDN)?
The analyst target price is $33.56, representing +152.3% upside from the current price of $13.30.
What is Viridian Therapeutics Inc's revenue?
TTM revenue is $70.85M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
3.53 — safe zone.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio19.35x
ROE-49.20%
Beta1.17
50D MA$22.68
200D MA$24.36
Shares out0.10B
Float0.10B
Short ratio—
Avg volume2.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—